Segmed Highlights Global Imaging Dataset and Microsoft Collaboration at RSNA 2025

Segmed has shared an update.

Segmed announced its participation in an AI Theater session at RSNA 2025 alongside Microsoft, focusing on how real-world imaging data (RWiD) can accelerate the development of regulatory-ready medical AI. The company highlighted that its global imaging dataset—comprising approximately 100 million imaging studies from more than 2,000 healthcare sites across five continents—is fully tokenized, de-identified, and positioned for use in fine-tuning healthcare foundation models, improving diagnostic performance across diverse populations, and supporting clinical validation and regulatory readiness.

For investors, this update underscores Segmed’s strategic positioning within the medical imaging and healthcare AI ecosystem as a data infrastructure provider rather than a standalone AI model developer. Collaboration with a major technology partner like Microsoft and visibility at a leading industry conference such as RSNA support Segmed’s credibility and may enhance its business development pipeline with pharmaceutical, medtech, and AI companies pursuing real-world data–driven solutions. The scale and regulatory-ready nature of its dataset could translate into recurring revenue opportunities through data licensing, collaborations, or platform subscriptions, particularly as regulators and healthcare providers increasingly emphasize validation on diverse, real-world data. Competitive dynamics in medical imaging data remain intense, but Segmed’s global footprint and focus on compliance and de-identification may provide a defensible niche as demand for high-quality training and validation datasets for medical AI continues to grow.